Hormonal contraception agents for planned use: a comparative analysis of clinico-pharmacological and economic characteristics and consumption
Keywords:hormonal contraceptives, assortment, economic affordability, consumer demand
Aim. To analyze and compare the assortment, affordability and consumer demand for hormonal contraceptives for planned use: oral hormonal contraceptives (OHC) of the combined contraceptive releasing-systems (CCRS) and hormonal contraceptives of prolonged action (HCPA) presented at the pharmaceutical market in 2018.
Materials and methods. The analysis of the assortment, economic affordability by the solvency adequacy index (Са.s.) and consumer demand by the number of OHC, CCRS, and HCPA packages sold according to the data of the “Morion” analytical system for 2018 was performed.
Results. OHC was represented by 40 trade names (TN), among them 35 TN were estrogens and gestagens in fixed combinations; gestagens and estrogens for sequential use were 3 TN; gestagens – 2 TN. CCRS and HCPA – 2 TN. The range of solvency adequacy index was: for OHC – 1.49-5.02 %; CCRS – 5.32-6.38 %; HCPA – 0.45-0.72 %. The number of packages sold was (in thousands): for OHC – 1879.4, among them 1708.1 – for estrogens and gestagens in fixed combinations; 156.7 – for gestagens and estrogens for sequential use; 14.6 – for gestagens; for CCRS – 27.3; for HCPA – 31.9.
Conclusions. At the pharmaceutical market of Ukraine, OHC are represented by the largest assortment compared to CCRS and HCPA and are in high demand. The most affordable hormonal contraceptives for planned use in Ukraine are CCRS. The most economical and affordable contraceptives are in high demand.
Radysh, Ya. F. (2013). Derzhavna polityka u sferi okhorony zdorovia (Vols. 1-2; Vol. 1). Kyiv: NADU, 396.
Tsili Staloho Rozvytku: Ukraina. Natsionalna dopovid. (2017). Available at: http://un.org.ua/images/SDGs_NationalReportUA_Web_1.pdf (Date of access: 02.09.2020).
Transforming our World: The 2030 Agenda for Sustainable Development. United Nations. (2015). Available at: https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf (Date of access: 02.09.2020).
Romanenko, T. H., Dovbnia, T. V. (2017). Zdorovie zhenshchiny, 10, 10-18. Available at: http://nbuv.gov.ua/UJRN/Zdzh_2017_10_3 (Date of access: 02.09.2020).
Hordiichuk, A. B. (2008). Zdorovia Ukrainy, 18/1. Available at: https://health-ua.com/article/16277-kombnovan-gormonaln-kontratceptivi--dosyagnennya-suchasno-kontratceptc (Date of access: 02.09.2020).
Vovk, I. B. (2018). Medychni aspekty zdorovia zhinky, 4 (117), 24-31. Available at: https://mazg.com.ua/ua-issue-article-1230 (Date of access: 02.09.2020).
WHO. (2015). Meditsynskie kryterii priemlemosti dlia ispolzovaniia metodov kontratseptsii. 5th ed. Zheneva, 195. Available at: http://www.euro.who.int/__data/assets/pdf_file/0005/348116/MEC-merged.pdf?ua=1 (Date of access: 02.09.2020).
Nakaz MOZ Ukrainy vid 21 sichnia 2014 roku No. 59 “Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy z pytan planuvanni simi”. zakon.rada.gov.ua. Available at: https://zakon.rada.gov.ua/rada/show/v0059282-14 (Date of access: 02.09.2020).
Mishchenko, O. Ya., Ostashko, V. F. (2019). Proceeding from Farmakoekonomika v Ukraini: stan ta perspektyvy rozvytku: materialy XI nauk.-prakt. internet-konf. (24 travnia 2019 r.). (pp. 74-76). Kharkiv: NFaU.
Mishchenko, O. Ya., Ostashko, V. F. (2019). Proceeding from Suchasna farmatsiia : materialy nauk.-prakt. konf. z mizhn. uch., prysviachenoi 20-y richnytsi zasnuvannia Dnia farmatsevtychnoho pratsivnyka Ukrainy (19-20 veresnia, 2019) (Vols. 1-2; Vol. 2). (pp. 82-84). Kharkiv: NFaU.
Mishchenko, O. Ya., Ostashko, V. F. (2019). Proceeding from Aktualni pytannia klinichnoi farmakolohii ta klinichnoi farmatsii : materialy nauk.-prakt. internet-konf. (22-23 zhovtnia, 2019). (pp. 151-159). Kharkiv: NFaU.
Mnushko, Z. M., Timaniuk, I. V. (2007). Visnyk farmatsii, 1 (49), 52-57.
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).